key articles
Circulating tumour cell counts as intermediate end points in castration-resistant prostate cancer
Wednesday, 27 August 2008 - Olmos et al. (2008) evaluated the association of circulating tumour cell (CTC) counts, before and after commencing treatment, with overall survival (OS) in patients with castration-resistant prostate...
Authors: Olmos et al.
ProsCan for Couples: Randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy
Wednesday, 27 August 2008 - Prostate cancer is the most common male cancer in the Western world. The most substantial long term morbidity from this cancer is sexual dysfunction with consequent adverse changes in couple and...
Authors: Chambers et al.
Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer
Tuesday, 26 August 2008 - The standard hormonal therapy with currently available antiandrogens and the leutinizing hormone releasing hormone (LHRH) analogs is not effective in the hormone-refractory stage of prostate cancer due...
Authors: Singh et al.
Nonhuman primates as models for studies of prostate specific antigen and prostatic diseases
Tuesday, 26 August 2008 - Because prostate specific antigen (PSA) is released at increased levels into the blood early in the development of prostate cancer, benign prostatic hyperplasia (BPH) and prostatitis, PSA is widely used...
Authors: Mubiru et al.
Multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer
Tuesday, 26 August 2008 - It is unclear whether postoperative salvage radiation therapy (SRT) and early adjuvant radiotherapy (ART) after radical prostatectomy lead to equivalent long-term tumor control. Trabulsi et al. (2008)...
Authors: Trabulsi et al.
Predictive significance of surgical margin after prostatectomy during prostate-specific antigen era
Tuesday, 26 August 2008 - The presence of positive surgical margins (PSMs) after prostatectomy for prostate cancer has long been an indicator of poor survival outcomes. However, with the downstaging of cancer occurring in the...
Authors: Mann et al.
Ultrasound-guided transrectal placement of drainage tube for prostatic abscess
Monday, 25 August 2008 - Prostatic abscess is a serious disease, and delay in adequate treatment may result in complications such as urethral, rectal, or paravesical fistulae and even urosepsis and death. Aravantinos et al....
Authors: Aravantinos et al.
Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy for prostate cancer
Thursday, 21 August 2008 - Inman et al. (2008) evaluated the long-term outcomes of men with prostate cancer and very high (> /=50 ng/mL) preoperative serum prostate-specific antigen (PSA) values that were treated with radical...
Authors: Inman et al.
Cognitive effects of hormone therapy for prostate cancer: a Review
Thursday, 21 August 2008 - Men receiving androgen-deprivation therapy (ADT) for prostate cancer can have several side effects from this treatment. A few recent studies have examined the cognitive implications of ADT and how they...
Authors: Nelson et al.
Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomy
Wednesday, 20 August 2008 - Tagawa et al. (2008) assessed subclinical haemostatic activation and clinical variables to predict bleeding during radical retropubic prostatectomy (RP), as haemostatic activation is common in cancer...
Authors: Tagawa et al.
